Popular topics to explore
Alkem Laboratories: Strong Domestic Pharma Momentum
ALKEM Alkem Laboratories delivered Q1 FY27 revenue growth of 10.9% YoY to ₹3,740 crore, while EBITDA rose 3.7% to ₹766 crore. PAT declined 21.7% to ₹520 crore, largely reflecting the high base and tax impact. Domestic sales grew 10.3% to ₹…
Alkem Laboratories Ltd Forms Death Cross
ALKEM Further technical analysis reveals a complex picture. The daily moving averages indicate a bearish stance, consistent with the Death Cross signal. Weekly and monthly MACD readings lean towards bearish and mildly bearish respectively,…
Can GLP-1 drugs change India’s productivity story?
A drug can change more than a patient’s weight. It can change how often someone misses work. A recent Danish study of Ozempic users found that long-term sick leave fell after treatment, while employment itself did not meaningfully increas…
Midcaps where both FIIs & DIIs increased stake last quarter
• IndusInd Bank • Radico Khaitan • KEI Industries • AIA Engineering • Alkem Labs • Exide Industries Heavy accumulation also seen in 👇 • Poonawalla Fincorp • JSW Energy • NHPC • Suzlon Energy • JSW Infra When both FIIs + DIIs buy together…
India’s 86-Year-Old Drug Law Is Finally Being Rewritten
Imagine buying a medicine for a child and assuming one thing: the system has already checked it. Recent cough-syrup tragedies showed why that assumption cannot always be taken for granted. India’s 1940 Drugs and Cosmetics Act is now 86 yea…
ALKEM
ALKEM
Alkem Laboratories is currently trading around ₹5,598 (10 Aug 2026 close), versus a 52-week range of ₹4,738–₹5,934. So the stock is trading close to its 52-week high.
📊 Fundamental picture
FY26 was strong:
Q4 FY26 revenue: ₹3,6…
Alkem Laboratories Limited Latest Updates
ALKEM Upcoming Q1 FY27 Financial Results Schedule
Alkem Laboratories has officially notified stock exchanges that its Board of Directors is scheduled to meet on Friday, August 14, 2026, to review and approve the unaudited standalone and co…
ALKEM - In a range
ALKEM continues to remain range-bound, with repeated 20-DMA and 50-DMA crossovers reflecting the absence of a sustained trend. The moving averages are nearly flat, indicating balanced buying and selling pressure. Support is placed near th…
Morning Market Insights | 7 August 2026
Indian equity markets are expected to open on a steady note as the broader trend remains positive despite the recent consolidation. Nifty continues to form a pattern of higher highs and higher lows on the daily chart, indicating that the un…
Alkem Laboratories Ltd – Bullish Breakout From Consolidation
ALKEM The stock has given a strong breakout from a prolonged consolidation zone with a bullish candle and rising momentum, indicating potential continuation of the uptrend.
🔎 Technical Observations:
• Breakout above consolidation range
•…
Alkem a compelling long-term investment case due to its strong domestic franchise, improving profitability, and growing international presence.
ALKEM
The company has established itself as one of India's leading pharmaceutical manufacturers, with a diversified portfolio across acute and chronic therapies. Its trusted brands, extensive distribution network, and consistent market s…
Pharma Stocks Under Pressure as U.S. Tariff Proposal Raises Export Concerns
The Nifty Pharma index declined around 1.6% after U.S. President Donald Trump announced a phased tariff plan on imported generic medicines, with a proposed two-year transition period before implementation. Although the tariffs are not expec…
Alkem Laboratories Strengthens Global Presence with Occlutech Acquisition
The pharma sector remained in focus after Alkem Laboratories completed the acquisition of a 51%–55% stake in Switzerland-based Occlutech Holding AG. The deal marks a strategic step for Alkem as it expands beyond pharmaceuticals into the fas…
Why I'm Bullish on Alkem Laboratories
ALKEM
Alkem Laboratories is one of India's leading pharmaceutical companies with a strong presence across branded generics, acute therapies, and an expanding international business. While the market often focuses on short-term quarterly…
Alkem’s Chronic Growth Bet
ALKEM Alkem Laboratories is positioning itself as a beneficiary of a big pharma trend: medicines that are used for a long time, not just one-time cures. For shareholders, that is generally positive because chronic therapies usually create…
ALKEM
## **Stocks in News — 2nd July 2026**
** ALKEM ** – Alkem Laboratories received **favourable Income Tax Appellate Tribunal (ITAT) orders** for **AY2018-19 to AY2022-23**, resulting in the deletion of tax disallowances worth **₹660.77 cr…
29th Jun · SEBI-Registered Analyst
"Invest like HNIs" by Clovek · 29th Jun
ALKEM
Alkem Medtech Private Limited executed a First Supplementary Agreement to acquire a controlling 51-55% stake in Occlutech Holding AG, a Swiss cardiac structural implant company. This amendment brings the acquisition closer to completion, ma…
India’s pharma sector is buzzing today (29 June 2026) with strong stock gains
India’s pharma sector is buzzing today (29 June 2026) with strong stock gains led by DRREDDY , AJANTPHARM , and IPCA Labs, while Alkem Labs advanced its overseas acquisition. Strides Pharma also announced a ₹100 crore divestment, and new…
India’s pharma sector was in the spotlight today (23 June 2026)
India’s pharma sector was in the spotlight today (23 June 2026) as the USFDA sought Indian help to tackle a global cancer‑drug shortage, SUNPHARMA Sun Pharma advanced its expansion plans, and a tragic fire hit a pharma plant in Andhra Pra…
ALKEM - Beginning Of Trend
ALKEM is showing strength in prices with a positive crossover and stock is likely basing out at 5350 and moving higher, also stochastic is showing positive crossover
